Aleksandra Rizo, M.D., Ph.D.

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Syndax Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get SNDX alerts

About Aleksandra Rizo, M.D., Ph.D.

Aleksandra Rizo, M.D., Ph.D. is recorded as Board Member at Syndax Pharmaceuticals Inc (SNDX) since May 15, 2024. Syndax Pharmaceuticals Inc reported in an 8-K filed May 15, 2024 that Aleksandra Rizo, M.D., Ph.D. was appointed Class III member, effective May 15, 2024. Syndax Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Syndax Pharmaceuticals Inc includes Michael A. Metzger (CEO and Board Member), Michael Metzger (CEO), Aaron A. Ondrey (CFO and Chief Accounting Officer) and 5 others.

“On May 15, 2024, the Board of Directors (the “Board”) of Syndax Pharmaceuticals, Inc. (the “Company”), unanimously voted to elect Aleksandra Rizo, M.D., Ph.D. to the Board, effectively immediately, and appointed her as a member of the Science and Technology Committee of the Board.”

Syndax Pharmaceuticals Inc Form 8-K, filed May 15, 2024 · Read the filing

Affiliation history

Syndax Pharmaceuticals Inc (SNDX)
Board Member

SEC 8-K

Current
2024-05-15–present

Company network

Syndax Pharmaceuticals Inc

SNDX

Current role

Biotechnology · Healthcare

Board Member

2024-05-15–present

Leadership on record at Syndax Pharmaceuticals Inc

Michael A. Metzger CEO, Board Member
Michael Metzger CEO
Aaron A. Ondrey CFO, Chief Accounting Officer
Daphne Karydas CFO
Keith Goldan CFO
Luke J. Albrecht General Counsel
Martin H. Huber, M.D. Board Member
Pierre Legault Board Member

Recent activity

Executive change Appointed: Class III member Syndax Pharmaceuticals Inc (SNDX)
2024-05-15